REFERENCES
1. Chen J, Zhang Q, Liu D, Liu Z. Exosomes: advances, development and potential therapeutic strategies in diabetic nephropathy. Metabolism 2021;122:154834.
2. American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes-2021. Diabetes Care 2021;44:S151-67.
3. Lecamwasam A, Ekinci EI, Saffery R, Dwyer KM. Potential for novel biomarkers in diabetes-associated chronic kidney disease: epigenome, metabolome, and gut microbiome. Biomedicines 2020;8:341.
4. Bakdash K, Schramm KM, Annam A, Brown M, Kondo K, Lindquist JD. Complications of percutaneous renal biopsy. Semin Intervent Radiol 2019;36:97-103.
5. Zhang W. Towards clinical implementation of circulating cell-free DNA in precision medicine. J Transl Genet Genom 2019;3:11.
6. Zampieri M, Bacalini MG, Barchetta I, et al. Increased PARylation impacts the DNA methylation process in type 2 diabetes mellitus. Clin Epigenetics 2021;13:114.
7. Zeng C, Zhang Z, Wang J, Chiu BC, Hou L, Zhang W. Application of the high-throughput TAB-Array for the discovery of novel 5-hydroxymethylcytosine biomarkers in pancreatic ductal adenocarcinoma. Epigenomes 2019;3:16.
8. Yuan EF, Yang Y, Cheng L, et al. Hyperglycemia affects global 5-methylcytosine and 5-hydroxymethylcytosine in blood genomic DNA through upregulation of SIRT6 and TETs. Clin Epigenetics 2019;11:63.
9. Zeng C, Stroup EK, Zhang Z, Chiu BC, Zhang W. Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy. Cancer Commun (Lond) 2019;39:12.
10. Song CX, Szulwach KE, Fu Y, et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol 2011;29:68-72.
11. Li W, Zhang X, Lu X, et al. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers. Cell Res 2017;27:1243-57.
12. Cai J, Chen L, Zhang Z, et al. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma. Gut 2019;68:2195-205.
13. Cai J, Zeng C, Hua W, et al. An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas. Neurooncol Adv 2021;3:vdab049.
14. Chiu BC, Chen C, You Q, et al. Alterations of 5-hydroxymethylation in circulating cell-free DNA reflect molecular distinctions of subtypes of non-Hodgkin lymphoma. NPJ Genom Med 2021;6:11.
15. Chiu BC, Zhang Z, You Q, et al. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma. Blood Adv 2019;3:2790-9.
16. Yang Y, Zeng C, Lu X, et al. 5-Hydroxymethylcytosines in Circulating Cell-Free DNA Reveal Vascular Complications of Type 2 Diabetes. Clin Chem 2019;65:1414-25.
17. Han L, Chen C, Lu X, et al. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes. Genomics 2021;113:79-87.
18. American Diabetes Association. Standards of medical care in diabetes-2017: summary of revisions. Diabetes Care 2017;40:S4-5.
19. Spanopoulos D, Okhai H, Zaccardi F, et al. Temporal variation of renal function in people with type 2 diabetes mellitus: a retrospective UK clinical practice research datalink cohort study. Diabetes Obes Metab 2019;21:1817-23.
20. Han D, Lu X, Shih AH, et al. A highly sensitive and robust method for genome-wide 5hmc profiling of rare cell populations. Mol Cell 2016;63:711-9.
21. Harrow J, Frankish A, Gonzalez JM, et al. GENCODE: the reference human genome annotation for the ENCODE project. Genome Res 2012;22:1760-74.
22. Liao Y, Smyth GK, Shi W. FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 2014;30:923-30.
23. Kundaje A, Meuleman W, Ernst J, et al. Roadmap epigenomics consortium. integrative analysis of 111 reference human epigenomes. Nature 2015;518:317-30.
24. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-504.
25. Wu T, Hu E, Xu S, et al. ClusterProfiler 4.0: a universal enrichment tool for interpreting Omics data. I. nnovation (N Y) 2021;2:100141.
26. Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res 2021;49:D605-12.
27. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci ;102:15545-50.
28. Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 2012;16:284-7.
29. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2012;40:D109-14.
30. Zou H, Hastie T. Regularization and variable selection via the elastic net. J Royal Statistical Soc B 2005;67:301-20.
31. Tang YL, Dong XY, Zeng ZG, Feng Z. Gene expression-based analysis identified NTNG1 and HGF as biomarkers for diabetic kidney disease. Medicine (Baltimore) 2020;99:e18596.
32. Dafinger C, Rinschen MM, Borgal L, et al. Targeted deletion of the AAA-ATPase Ruvbl1 in mice disrupts ciliary integrity and causes renal disease and hydrocephalus. E. xp Mol Med 2018;50:1-17.
33. Huang F, Wang Q, Guo F, et al. FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease. EBioMedicine 2019;48:491-504.
34. Anders HJ, Lech M. NOD-like and Toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner. Kidney Int 2013;84:225-8.
35. Qu W, Han C, Li M, Zhang J, Li L. Revealing the underlying mechanism of diabetic nephropathy viewed by microarray analysis. Exp Clin Endocrinol Diabetes 2015;123:353-9.
36. Nunemaker CS, Chung HG, Verrilli GM, Corbin KL, Upadhye A, Sharma PR. Increased serum CXCL1 and CXCL5 are linked to obesity, hyperglycemia, and impaired islet function. J Endocrinol 2014;222:267-76.
37. Geng XD, Wang WW, Feng Z, et al. Identification of key genes and pathways in diabetic nephropathy by bioinformatics analysis. J Diabetes Investig 2019;10:972-84.
38. Zhang Z, Zeng C, Zhang W. Considerations before the application of 5-hydroxymethylation levels of long non-coding RNAs for non-invasive cancer diagnosis. Extracell Vesicles Circ Nucl Acids 2022;3:10-3.
